Imago BioSciences, Inc.
DelistedCIK 1623715fmd_1GH00SBF5V7NYMJ3R9JKQAPEFEManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2022, 11 periods
Latest annual · FY2021
Millions- Operating income
- (43)
- Net income
- (42)
- Free cash flow
- (17)
Latest quarter · Q3 FY2022
Millions- Operating income
- (18)
- Net income
- (17)
Imago BioSciences, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Operating income | -$42.5 million | -$18.1 million | 10-K 2022-03-24 · proof | |
| Net income | -$42.3 million | -$17.8 million | 10-K 2022-03-24 · proof | |
| Cash from operating activities | -$39.8 million | -$16.9 million | 10-K 2022-03-24 · proof | |
| Total assets | $224.8 million | $98.9 million | +127.2% | 10-K 2022-03-24 · proof |
| Total liabilities | $10.1 million | $5.1 million | +97.7% | 10-K 2022-03-24 · proof |
| Cash and cash equivalents | $11.2 million | $19.3 million | -41.7% | 10-K 2022-03-24 · proof |
- What was Imago BioSciences, Inc.'s operating income in fiscal 2021?
- Imago BioSciences, Inc. reported operating income of -$42.5 million for fiscal 2021 (the year ended Dec 31, 2021), against -$18.1 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What was Imago BioSciences, Inc.'s net income in fiscal 2021?
- Imago BioSciences, Inc. reported net income of -$42.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$17.8 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What was Imago BioSciences, Inc.'s cash from operating activities in fiscal 2021?
- Imago BioSciences, Inc. reported cash from operating activities of -$39.8 million for fiscal 2021 (the year ended Dec 31, 2021), against -$16.9 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What are Imago BioSciences, Inc.'s total assets?
- As of Dec 31, 2021, Imago BioSciences, Inc. reported total assets of $224.8 million, against $98.9 million a year earlier (+127.2%). Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What are Imago BioSciences, Inc.'s total liabilities?
- As of Dec 31, 2021, Imago BioSciences, Inc. reported total liabilities of $10.1 million, against $5.1 million a year earlier (+97.7%). Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
- What are Imago BioSciences, Inc.'s cash and cash equivalents?
- As of Dec 31, 2021, Imago BioSciences, Inc. reported cash and cash equivalents of $11.2 million, against $19.3 million a year earlier (-41.7%). Source: the 10-K filed with the SEC on Mar 24, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1623715&period_type=annual&limit=5"Information only, not investment advice.